cava headset vertigo diagnosis

Researchers Develop New, Highly Accurate, Diagnostic Headset for Dizziness

UK researchers, from the University of East Anglia and Norfolk and Norwich University Hospital, have developed a wearable headset for diagnosing dizziness. A clinical investigation of the Continuous Ambulatory Vestibular Assessment (CAVA) device was recently published in the journal Scientific Reports. After capturing 9000 hours of eye and head movement data from a group of…

Read More
dizzy vertigo treatment

Researchers Discover New Form of Vertigo That Can be Treated

As many audiologists know, vertigo has a myriad of causes and the treatment process can be complex and time-consuming. Researchers in South Korea, however, have identified a new type of vertigo that may be effectively treated with medication. A study, published online last week in the journal Neurology identified what they consider a new condition,…

Read More
dizziness drug trial

Clinical Trial For Motion Sickness Drug Now Over 50% Enrolled

WASHINGTON, DC — GT Biopharma Inc., a clinical stage biotech company, announced the Proof-of-Concept clinical trial of its novel drug treatment for motion sickness, GTP-011, is now more than 50% enrolled. According to the announcement, the trial is a single-blind, placebo-controlled, cross-over study. The study’s primary objective will be to demonstrate the efficacy of transdermal GTP-011…

Read More
bppv vertigo guidelines

New Best Practice Guidelines Issued for BPPV, One of the Most Common Causes of Vertigo

ALEXANDRIA, VIRGINIA — On March 1st, the American Academy of Otolaryngology—Head and Neck Surgery Foundation (AAO-HNSF) published an updated clinical practice guideline for healthcare providers on benign paroxysmal positional vertigo (BPPV). The updated guideline, Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo, provides evidence-based recommendations to healthcare providers on diagnosis and treatment of BPPV. Additionally, the…

Read More
dizziness device

No More Dizzy Pills? Device to Treat Motion Sickness likely Available “Within 5 to 10 Years”

LONDON, UNITED KINGDOM – Researchers at the Imperial College of London (ICL) are developing an effective new treatment for motion sickness, which they say could become available over the counter sometime in the next five to ten years. Instead of developing a pharmaceutical treatment for motion sickness and dizziness, researchers at ICL have instead focused on…

Read More

As use of wind power grows, so do fears that turbines may be hazardous to your ears

There is no more fiercely disputed topic these days than what source of energy we should draw on to power our ever-more power-consuming world. Words and phrases like greenhouse gases, war on coal, Solyndra, Keystone pipeline, fracking, Fukushima Daiichi and Chernobyl, energy independence, rising sea level, global warming and scientific conspiracy are invoked to defend…

Read More

Boston Marathon bombings are still taking a heavy toll on victims’ hearing

BOSTON—More than a year after the Boston Marathon bombings of April 15, 2013, scores of victims of the terrorist action are still suffering from hearing loss, tinnitus, and other conditions resulting from exposure to the two explosions. So report 15 physicians and audiologists writing in the December 2014 issue of Otology & Neurotology. In the…

Read More